SCHEMBL166330

SCHEMBL166330

Cc1cc(Nc2nc(C(=O)c3ccc(F)cc3)nc3scc(C)c23)n[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 8/20 0.54
AURKB Q96GD4 4/20 0.54
JAK2 O60674 4/20 0.40
JAK3 P52333 4/20 0.40
CYP3A4 P08684 3/20 0.40
CYP2C8 P10632 3/20 0.40
CYP2C9 P11712 3/20 0.40
JAK1 P23458 3/20 0.40
TYK2 P29597 3/20 0.40
CYP2C19 P33261 3/20 0.40
ADORA3 P0DMS8 2/20 0.40
CYP1A2 P05177 1/20 0.40
SRC P12931 2/20 0.39
GSK3B P49841 2/20 0.39
NTRK1 P04629 2/20 0.39
PAK4 O96013 2/20 0.39
PLK4 O00444 1/20 0.39
EIF2AK2 P19525 1/20 0.39
GSK3A P49840 1/20 0.39
RET P07949 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166590 0.85 AURKA (0.55) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL173921 0.85 AURKA (0.38) AURKAAURKBADORA3
SCHEMBL174808 0.85 AURKA (0.60) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL174958 0.82 AURKA (0.59) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL164643 0.80 AURKA (0.61) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL175237 0.80 AURKA (0.64) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL3773701 0.79 AURKA (0.66) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL173218 0.79 AURKA (0.76) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL174382 0.79 AURKA (0.71) AURKAAURKBJAK2JAK3CYP3A4
SCHEMBL174414 0.79 AURKA (0.73) AURKAAURKBJAK2JAK3CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP claimed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO claimed
EP-2611812-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2013-07-10 EP disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed
WO-2012030894-A1 THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORPORATION (US) 2012-03-08 WO disclosed